by Kall Kwik WGC | Dec 12, 2018 | Free Library
November, 2018 SMM-187 Midas Touch When smart, but small, science can turn old ideas into gold.
by Kall Kwik WGC | Oct 18, 2018 | Free Library
October, 2018 SMM-186 Medtech’s Mixed-up Monsters If nature abhors a vacuum, traditional theory has it that investors hate conglomerates; markets tend to value aggregates of different businesses at less than the sum of their parts. How...
by Kall Kwik WGC | Oct 9, 2018 | Free Library
September, 2018 SMM-185 Big pharma, little pharma Why, for smaller firms, imitating large firms may be a less viable approach than imitating other small firms.
by Kall Kwik WGC | Aug 14, 2018 | Free Library
July, 2018 SMM-184 Brand teams: why are some smarter than others? In practice, all brand teams recruit from the same labour pool, adopt industry-standard processes and buy data from the usual sources. It’s unrealistic to expect your people to be...
by Kall Kwik WGC | Aug 2, 2018 | Free Library
August, 2018 SMM-183 Keytruda’s Secret Sauce Why Merck’s position in oncology is about much more than a good product.
by Kall Kwik WGC | Jul 9, 2018 | Free Library
June, 2018 SMM-180 Less is more In most life science companies, the brand plan document is not fit for purpose. Intended to communicate the plan and gain commitment, It is typically a time-consuming tome that is rarely read and often ridiculed....
